Prevalence and correlates of areca nut use among psychiatric patients in India

Drug and Alcohol Dependence

Volumn 69, Issue 3, 2003, Pages 311-316

  Chandra, Prabha S ^a   Carey, Michael P ^b   Carey, Kate B ^b   Jairam, K R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^b SYRACUSE UNIVERSITY   (United States)

Author keywords

Areca nut; Betel nut; India; Severe mental illness; Substance use

Indexed keywords

ADULT; AGE; ANALGESIA; ARTICLE; BETEL NUT; BIPOLAR DISORDER; CONTROLLED STUDY; CORRELATION ANALYSIS; DIGESTION; FEMALE; HUMAN; INDIA; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MENTAL DISEASE; MENTAL PATIENT; MOOD; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; SOCIALIZATION; SOCIOECONOMICS; SUBSTANCE ABUSE; TASK PERFORMANCE;

ADULT; ARECA; BIPOLAR DISORDER; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEVELOPING COUNTRIES; FEMALE; HUMANS; INDIA; MALE; MENTAL DISORDERS; MOTIVATION; NUTS; PATIENT ADMISSION; PSYCHIATRIC DEPARTMENT, HOSPITAL; SUBSTANCE-RELATED DISORDERS;

ARECA CATECHU; NICOTIANA TABACUM; PIPER BETEL;

EID: 0037375154     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(02)00329-0     Document Type: Article

References (28)

1. Abi-Dargham A., Laruelle M., Krystal J., D'Souza C., Zoghbi S., Baldwin R., Seibyl J., Mawlawi O., de Erasquin G., Charney D., Innis R. No evidence of altered in vivo benzodiazepine receptor binding in schizophrenia. Neuropsychopharmacology. 20:1999;650-661.
2. Boucher B.J., Mannan N. Metabolic effects of the consumption of Areca catechu. Addict. Biol. 7:2002;103-110.
3. Cawte J. Psychoactive substances of the South Seas: betel, kava and pituri. Aust. New Zealand J. Psychol. 19:1985;83-87.
4. Chu N.-S. Neurological aspects of areca and betel chewing. Addict. Biol. 7:2002;111-114.
5. Croucher R., Islam S. Socio-economic aspects of areca nut use. Addict. Biol. 7:2002;139-146.
6. Dar A., Khatoon S. Behavioral and biochemical studies of dichloromethane fraction from the areca cetchu nut. Pharmacol. Biochem. Behav. 65:2000;1-6.
7. Deahl M.P. Psychostimulant properties of betel nuts. Br. Med. J. 294:1987;841.
8. Deng J., Ger J., Tsai W., Kao W., Yang C. Acute toxicities of betel nut: rare but probably overlooked events. J. Toxicol. Clin. Toxicol. 39:2001;355-360.
9. Dixon L., Haas G., Weiden P., Sweeney J., Frances A. Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am. J. Psychiatry. 148:1991;224-230.
10. Gupta P.C. Survey of sociodemographic characteristics of tobacco use among 99 598 individuals in Bombay, India using handheld computers. Tob. Control. 5:1996;114-120.
11. Gupta P.C., Warnakulasuriya S. Global epidemiology of areca nut usage. Addict. Biol. 7:2002;77-83.
12. Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerström K.O. The Fagerström test for nicotine dependence: a revision of the fagerström tolerance questionnaire. Br. J. Addict. 86:1991;1119-1127.
13. Johnston G., Krogsgaard-Larsen P., Stephanson A. Betel nut constituents as inhibitors of gamma-aminobutyric acid uptake. Nature. 258:1975;627-628.
14. Lodge D., Johnston G., Curtis D., Brand S. Effects of the areca nut constituents arecaidine and guvacine on the action of GABA in the cat central nervous system. Brain Res. 136:1977;513-522.
15. Malaowalla A., Silverman S., Mani N., Bilimoria K., Smith L. Oral cancer in 57 518 industrial workers of Gujarat, India: a prevalence and followup study. Cancer. 37:1976;1882-1886.
16. Mehta F., Pindborg J., Gupta P., Daftary D. Epidemiologic and histologic study of oral cancer and leukoplakia among 50 915 villagers in India. Cancer. 24:1969;832-849.
17. Merchant A., Husain S., Hosain M., Fikree F., Pitiphat W., Siddiqui A., Hayder S., Hayder S., Ikram M., Chuang S., Saeed S. Paan without tobacco: an independent risk factor for oral cancer. Int. J. Cancer. 86:2000;128-131.
18. Nelson B., Heischober B. Betel nut: a common drug used by naturalized citizens from India, Far East Asia, and the South Pacific Islands. Ann. Emerg. Med. 34:1999;238-243.
19. Norton S. Betel: consumption and consequences. J. Am. Acad. Dermat. 38:1998;81-88.
20. Phukan R., Ali M., Chetia C., Mahanta J. Betel nut and tobacco chewing; potential risk factors of cancer of oesophagus in Assam, India. Br. J. Cancer. 85:2001;661-667.
21. Regier D., Farmer M., Rae D., Locke B., Keith S., Judd L., Goodwin F. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) study. J. Am. Med. Assoc. 264:1990;2511-2518.
22. Reynolds G., Zhang Z., Beasley C. Neurochemical correlates of cortical GABAergic deficits in schizophrenia: selective losses of calcium binding protein immunoreactivity. Brain Res. Bull. 55:2001;579-584.
23. Saunders J., Aasland O., Babor T., De La Fuente J., Grant M. Development of the alcohol use disorders screening test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption II. Addiction. 88:1993;791-804.
24. Skinner H. The drug abuse screening test. Addict. Behav. 7:1982;363-371.
25. Smythies J. Betel nut as a GABA blocker. Am. J. Psychol. 134:1977;822.
26. Strakowski S.M., Sax K.W., McElroy S.L., Keck P.E. Jr, Hawkins J.M., West S.A. Course of psychiatric and substance abuse syndromes co-occurring with bipolar disorder after a first psychiatric hospitalization. J. Clin. Psychol. 59:1998;465-471.
27. Sullivan R.J., Allen J.S., Otto C., Tiobech J., Nero K. Effects of chewing betel nut (Areca catechu) on the symptoms of people with schizophrenia in Palau, Micronesia. Br. J. Psychol. 177:2000;174-178.
28. Warner R., Taylor D., Wright J., Sloat A., Springett G., Arnold S., Weinberg H. Substance use among the mentally ill: prevalence, reasons for use, and effects on illness. Am. J. Orthopsychol. 64:1994;30-39.